Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has […]

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is making strategic moves as it progresses with pre-clinical and clinical trials. One of those steps includes […]

Q1 Report Shows Signs of Rising, Record-level Contracts for AmpliTech Group Inc.’s (NASDAQ: AMPG) Radio Frequency Technologies

AmpliTech Group, a designer and developer of technology that enhances radio frequency (“RF”) transmissions for satellites, 5G, IoT and other applications recently reported record order bookings and orders in progress under deadline Thaw in COVID pandemic’s business impact is very encouraging for future business opportunities Products serve satellite communications, space, telecommunications (5G/6G) and military defense […]

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

Science continues to substantiate use of cannabis for pain relief, epileptic seizure control Research suggests strains with optimized cannabinoid profiles are more effective PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles Genetic cultivation techniques allow selection for specific growing environments, maximum yields With a growing list of use cases spanning […]

FingerMotion Inc. (FNGR) Tackling the Market Through Unmatched Innovation and Technology

FingerMotion’s strategy is to rapidly expand its user base through organic means utilizing a broad range of innovative applications It handles over 500,000 transactions every day for its mobile payment and recharge service, all facilitated by superior technology Technology and innovation are at the center of FingerMotion’s operations and activities and will clearly play a […]

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results

CYBN subsidiary Adelia Therapeutics has reached earn-out milestones. Adelia’s earn-out milestones contributed to positive preclinical results with multiple proprietary psychedelic molecules. Cybin’s development of these compounds differentiates it from companies focused on naturally occurring psychedelic compounds. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that earn-out milestones have […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships

PlantX Life recently launched as a seller on both Walmart Canada Marketplace and Hudson’s Bay Marketplace The launches appear to be leveraging the changes and trends brought about by the COVID-19 pandemic In addition, the agreements are part of PlantX’s growth strategy The company will offer thousands of its products on both platforms As the […]

 

From Our Blog

SS Innovations International Inc. (NASDAQ: SSII) CEO Outlines Strategy to Expand Affordable Robotic Surgery 

July 13, 2026

For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview with Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, who discussed the company’s strategy […]

Rotate your device 90° to view site.